Content Block Tag: NRG-HN001: Nasopharyngeal Cancer Treatment Based on DNA

‘Text/HTML’ of page ‘NRG-HN001: Nasopharyngeal Cancer Treatment Based on DNA’

Am I eligible for this study? If you are over the age of 18 nasopharyngeal cancer (in the head and neck region) that has not spread to other parts of the body, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. […]

‘Text/HTML’ of page ‘NRG-HN001: Nasopharyngeal Cancer Treatment Based on DNA’

About This Study NRG-HN005 is a clinicalstudy for people with Human Papillomavirus (HPV) positive oropharyngeal cancer. This study has two parts called “phase II” and “phase III”. Typically, people with your type of cancer are treated with radiation therapy and chemotherapy, also known as the “usual approach”. For patients who get the usual approach […]

‘Text/HTML’ of page ‘NRG-HN001: Nasopharyngeal Cancer Treatment Based on DNA’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-HN001: Nasopharyngeal Cancer Treatment Based on DNA’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-HN001: Nasopharyngeal Cancer Treatment Based on DNA’

The NRG-HN001 Study FAQ